Colgate-Palmolive (CL) Holdings Raised by Trillium Asset Management LLC

Trillium Asset Management LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 34.8% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 5,016 shares of the company’s stock after purchasing an additional 1,294 shares during the period. Trillium Asset Management LLC’s holdings in Colgate-Palmolive were worth $365,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the business. OLD Second National Bank of Aurora bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $109,000. Krilogy Financial LLC grew its position in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares during the period. Hanson & Doremus Investment Management grew its position in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the period. Captrust Financial Advisors bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $122,000. Finally, Harbour Capital Advisors LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at approximately $121,000. 72.83% of the stock is owned by institutional investors and hedge funds.

CL has been the topic of a number of recent research reports. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a research note on Tuesday, December 19th. Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Finally, SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $76.33.

In other news, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the transaction, the insider now owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders sold a total of 181,048 shares of company stock worth $13,168,995 over the last quarter. Corporate insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE CL) opened at $75.48 on Wednesday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. The stock has a market cap of $65,989.61, a P/E ratio of 29.14, a price-to-earnings-growth ratio of 3.44 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the prior year, the company posted $0.73 EPS. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/27/colgate-palmolive-cl-holdings-raised-by-trillium-asset-management-llc.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

What are top analysts saying about Colgate-Palmolive? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit